Novan, Inc. (NOVN) financial statements (2021 and earlier)

Company profile

Business Address 4105 HOPSON ROAD
MORRISVILLE, NC 27560
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments36148335
Cash and cash equivalents36148335
Prepaid expense2    
Deferred costs0000 
Disposal group, including discontinued operation0    
Other undisclosed current assets62111
Total current assets:44169436
Noncurrent Assets
Operating lease, right-of-use asset 2
Property, plant and equipment211161716
Intangible assets, net (including goodwill)00000
Intangible assets, net (excluding goodwill)00000
Restricted cash and investments 1111
Other noncurrent assets0010 
Total noncurrent assets:313171717
TOTAL ASSETS:4729262152
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities33458
Accounts payable12103
Accrued liabilities11122
Employee-related liabilities10122
Deferred revenue34
Debt01000
Deferred revenue and credits2 
Contract with customer, liability4
Other undisclosed current liabilities24116
Total current liabilities:9139813
Noncurrent Liabilities
Long-term debt and lease obligation05000
Long-term debt, excluding current maturities0    
Capital lease obligations000
Operating lease, liability 5
Liabilities, other than long-term debt9847 
Deferred revenue and credits7 
Deferred revenue87
Contract with customer, liability3
Other liabilities110  
Derivative instruments and hedges, liabilities  1  
Other undisclosed noncurrent liabilities2626888
Total noncurrent liabilities:353812158
Total liabilities:4451212321
Stockholders' equity
Stockholders' equity attributable to parent3(22)5(2)31
Common stock00000
Treasury stock, value(0)(0)(0)(0)(0)
Additional paid in capital252198178158154
Accumulated deficit(249)(220)(172)(160)(123)
Total stockholders' equity:3(22)5(2)31
TOTAL LIABILITIES AND EQUITY:4729262152

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Gross profit:5562 
Operating expenses(35)(36)(35)(38)(60)
Operating loss:(30)(31)(29)(36)(60)
Nonoperating income (expense)1016(1)0
Investment income, nonoperating    0
Other nonoperating income100 0
Interest and debt expense (0)(1) (0)
Net loss:(29)(30)(14)(37)(60)
Other undisclosed net income attributable to parent 01 0
Net loss available to common stockholders, diluted:(29)(30)(13)(37)(60)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(29)(30)(14)(37)(60)
Comprehensive loss:(29)(30)(14)(37)(60)
Other undisclosed comprehensive income, net of tax, attributable to parent 01  
Comprehensive loss, net of tax, attributable to parent:(29)(30)(13)(37)(60)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: